Self-paying customers historically had to fork out nearly $1000 per month for injectable GLP-1 drugs, although Novo Nordisk slashed this price at the end of last year
The formulation, inactive ingredients, manufacturing process, and quality control standards may differ
Appetite Regulation and Eating Behavior Retatrutide produces profound changes in appetite regulation and eating behaviors that contribute significantly to weight loss efficacy
He was reluctant to quit, not just because of the blood sugar benefits, but because of the overall health effects these medications have on the other parts of the body, including the heart, liver, and kidneys
[14] [15] Prescribers should refer to the FDA Prescribing Information for Egrifta/Egrifta SV for full contraindication and monitoring guidance, as no UK SmPC exists
Recommended monitoring protocol: Baseline: Full thyroid panel (TSH, free T4, free T3, TPO antibodies, thyroglobulin antibodies) plus thyroid ultrasound before starting GLP-1 therapy 6-8 weeks after starting GLP-1: Recheck TSH and free T4